Pricing Log in Create free account

Cogent Biosciences, Inc. (COGT) vs Veradermics Incorporated (MANE)

Cogent Biosciences, Inc. and Veradermics Incorporated are both Biotechnology companies. Cogent Biosciences, Inc. and Veradermics Incorporated are of similar size ($5.4B and $5.1B). Across the 9 metrics below, Veradermics Incorporated leads on 7 and Cogent Biosciences, Inc. on 2.

Valuation

Metric COGT MANE Biotechnology median
P/E n/m n/m 10.26
P/S 219.67 n/m 9.18
P/B 10.88 6.37 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 195.11 n/m 8.98
Earnings yield (7.26%) (35.79%) (34.89%)
Free cash flow yield (6.08%) (2.37%) (24.52%)

Profitability

Metric COGT MANE Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (146.55%) 0.00% (50.12%)
Return on assets (68.00%) (20.86%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric COGT MANE Biotechnology median
Revenue growth (TTM) 110.23% — 6.26%
EPS growth (last fiscal year) (11.34%) (211.38%) 29.88%
Revenue growth, 5-year CAGR 21.39% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric COGT MANE Biotechnology median
Debt to equity 0.42 0.00 0.00
Current ratio 13.57 70.53 4.89
Net debt to EBITDA 2.04 1.96 1.01

Dividend

Metric COGT MANE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric COGT MANE Biotechnology median
Market cap 5.13b 5.37b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack